Ariadne announces a new collaboration with the BIO-NMD consortium led by Professor Alessandra Ferlini at the University of Ferrara,
Italy. BIO-NMD is a three year EU-funded research project concentrating on the search for non-invasive
biomarkers in people with Duchenne and Becker muscular dystrophies and Collagen VI myopathies. The consortium, along with leading European academic and industry partners will work to identify non-invasive
biomarkers for
monitoring neuromuscular
diseases (NMDs). Utilizing a myriad of OMIC sciences (genomic, transcriptomic, proteomic) and
bioinformatics, the consortium hopes to bring qualified biomarkers for ongoing and further
clinical trials.
Ariadne’s focus will be on providing
bioinformatics tools for identifying functional pathways, potential targets and data outflow integration. The team will use its
software, Pathway Studio®, as a core to integrate the data and
information flow, in addition to using its expertise in information
extraction to develop a literature-derived NMD biological knowledgebase of related processes and
diseases. Specifically, Ariadne will build mechanistic models and pathways for NMD and interpret OMIC data generated by the consortium and partners in the context of NMD knowledgebase and networks.
BIO-NMD’s coordinator and chair of the steering committee, Professor Alessandra Ferlini (University of Ferrara, Italy) said, “The participation of Ariadne as partners together with
Inserm is crucial for the project. Developing bioinformatic tools for OMIC studies
analysis is essential and guarantees success to the project. In addition, it reinforces collaboration between
academics and industries, again a key point for successful research to be translated into
clinics”
“We have always worked to establish strong
collaborations with our clients”, says Gabriella Armin, Director of Marketing for Ariadne. “Given the importance of this project, we are proud to not only provide the technology to enable this type of innovative discovery research, but contribute scientifically as team members. Our technological expertise in knowledge enrichment continues to provide crucial bioinformatics tools for visualizing the complexity found in
biology.”